humanitarian
Archived signal Translated · Українська · 2–5m lag
Звіт про людські ліки (EPAR): Beromun, tasonermin, Date of Permission: 12/"? 1999, revision: 16, status: Authorized
Звіт з питань людських ліків (EPAR) (EDAR): Azantive, ablibercecopet, Date of Pentification: 13/01/2025, revision: 6, Status: Authorized
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewЗвіт про людські ліки (EPAR): Beromun, tasonermin, Date of Permission: 12/"? 1999, revision: 16, status: AuthorizedEMA What Is NewЗвіт про людські ліки (EPAR): Beromun, tasonermin, Date of Permission: 12/"? 1999, revision: 16, status: AuthorizedEMA What Is NewHuman medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Iressa, gefitinib, Date of authorisation: 24/06/2009, Revision: 16, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Iressa, gefitinib, Date of authorisation: 24/06/2009, Revision: 16, Status: AuthorisedEMA What Is NewЗвіт з питань людських ліків (EPAR): Yesafili, aflibsepcept, Date of Pritorization: 15/09/2023, modifierization (EDAR): 9, Status: AuthorizedEMA What Is NewЗвіт з питань людських ліків (EPAR): Yesafili, aflibsepcept, Date of Pritorization: 15/09/2023, modifierization (EDAR): 9, Status: AuthorizedEMA What Is NewHuman medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised1 recorded state
Signal first indexedP2 · 99% quality · 2 sources